Multiple Sclerosis Patients with Markedly Low Intrathecal Antibody Response in Sri Lanka
Multiple sclerosis (MS) is a heterogeneous disease which is poorly studied in Asia, where the disease is known to be rare with significant differences in clinical and radiological presentations and intrathecal antibody response. Therefore the objective of this study was to determine clinical present...
Main Authors: | S. M. K. Gamage, I. Wijeweera, S. B. Adikari, Katharina Fink, Jan Hillert, Anna Fogdell-Hahn, H. M. A. Sominanda |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Multiple Sclerosis International |
Online Access: | http://dx.doi.org/10.1155/2018/5342936 |
Similar Items
-
Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
by: Nicky Dunn, et al.
Published: (2020-10-01) -
Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosis.
by: Jenny Link, et al.
Published: (2014-01-01) -
Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis.
by: Lenka Fialová, et al.
Published: (2011-01-01) -
Analysis of intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis patients
by: Gürkov, Robert
Published: (2005) -
Intrathecal Inflammation in Progressive Multiple Sclerosis
by: Salvatore Monaco, et al.
Published: (2020-11-01)